Rochester Clinical Research is enrolling adults ages 18 and older for a study looking at a new treatment for people with type 2 diabetes, high blood pressure, and heart disease.
This study is enrolling at both Rochester & Buffalo locations.
Type 2 Diabetes, Heart & Blood Pressure Study
Age Range:
18
Gender:
Male and Female
Location:
Buffalo, New York
About the Study
The purpose of this study is to see if adding an investigational medicine to a commonly used diabetes medication may help lower the risk of serious heart problems, such as heart failure or heart-related death. Researchers will also look at how the treatment may affect blood pressure and kidney health.
This study will include regular health check-ins, lab tests, and study visits to help monitor your safety and how well the treatment is working over time.
Qualifications
You May Qualify if you are:
- 18 years or older
- Diagnosed with type 2 diabetes
- Have high blood pressure
- Have a history of heart or blood vessel disease (such as prior heart issues)
- Currently receiving standard medical care for these conditions
Other qualifications apply during screening.
FEATURED STUDIES
Researchers are studying an investigational medication to see how effective it may be as a potential weight reduction treatment. If […]
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]
Adults who are overweight or obese and currently using semaglutide (Ozempic®/Wegovy®) or tirzepatide (Mounjaro®/Zepbound®) may qualify for a research study […]